.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Multiphase combined treatment for adults with GBM, including individualized multimodal immunotherapy: Single institute real world medical data in the light of clinical trial research data

Appointment

Date: 29/09/2023

Time: 15:42 – 15:54

Talk time: 10 Min.

Discussion time: 2 Min.

Location / Stream:

Session

Clinical applications & Trial

Topic

Clinical Applications & Trials

Authors

Stefaan Van Gool (Cologne, DE), Dr. Peter Van de Vliet (Cologne, DE), Dr. Linde Kampers (Cologne, DE), Dr. Jennifer Makalowski (Cologne, DE), Dr. Tobias Sprenger (Cologne, DE), Professor Volker Schirrmacher (Cologne, DE), Dr. Wilfried Stücker (Cologne, DE)